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Summary Introduction
Williams syndiome (WS) is a developmental disoidet with Williams syndrome (WS) is a neurodevelopmental elisor-
variable phenotypic expression associated, in most cases, der characterized by distinctive facial features, mental
with a hemizygous deletion of patt of chiomosomal band disability with unique cognitive and personality profiles,
7q.11.23 that includes the elastin gene (ELN). We have vascular stenoses, growth retardation, connective tissue
investigated the frequency and size of the deletions deter- abnormalit;es, andi occasionally, infantile hypercalce-
mined the parental origin and correlated the molecular mja (Martinetal# 1984; Burn 1986; Morris et ah 1988;
lesu ts with t t c  c inical findings in 65 WS patients. Herni- Udwin 1990). The disorder was described independently
zygosity at the ELN locus was established by typing of two by W iniams et aL (j 96:1) and Beuren et ah (1962) as a
intiagentc polymorp lisms, quantitative Soutiern analysis, syndrome involving unusual facial appearance, su~
and/or  ^ . Po ymotphic markets covering t ie deletion pravaJvar aortic stenosis and mental retardation. It is
and flan ang regions were ordeied by a combination of usually a sporadic occurrence with an estimated inci-
genetic and physical mapping. Genotyping of WS patients dence 0f [ 20,000 live births (Martin et al. 1984;
an avai ab e parents for 13 polymorphisms revealed that Grimm and Wesselhoeft 1980), although a few reports
of 65 clmica y e ned WS patients, 61 (94 /o) had a dele- Qp affectcd parents and children are consistent with au-
tion of the ELN locus and were also hcmizygous (or non- C()Soma, dominant inheritance (Morris et ah 1993;
in ounative) at oci D7S489B, D7S2476, D7S613, Sadler et al. 1993). When it was found that elastin (ELN)
1 7S2 72, and D7 870. None of the foui patients with- ^ene disrilpj;jons are causative in the autosomal domi-
out ELN de etion was hcmizygous at any of the polymot- nant disordcr supravalvar aortic stenosis (SVAS) (Cut"
phic loci studied. All patients were heterozygous (or nonin- ran et aL [993; Ewart et ah 1994; Olson et al. 1995),
ounative) fot centiomeiic (D7S1816, D7S1483, and hcmizygous deletions of ELN were described in the ma-
D7S653)^and telomenc (D7S489A, D7S675, and D7S669) j0rity of WS patients (Ewart et al. 1993; Borg et al.
1995; Kotzot et al. 1995*7; Lowery et al. 1995; Mari et
al. 1995; Nickerson et al. 1995;). The more complex
phenotype in WS as compared to SVAS suggests a micro-
, , , deletion with haploinsufficiency at ELN being response
parenta origin, all deletions were de novo, and 18 were ble on, for the cardbvaseular features and possibly
paternally and 21 maternally derived. Comparison of dim- the conilcctivc tissut. abnormalities, while haploinsulH-
__  I  ___ A  - __  * ___ a  I  . _  „ ^  .A  _  _   ^ __. __ _1 _  _  . > 1  . . . > 1  .  . . . .  B  _ _  i  ^
flanking loci. The genetic distance between the most-cen- 
tromeric deleted locus, D7S489B, and the most-telomeric 
one, D7S1870, is 2 cM. The breakpoints cluster at ~1 
cM to either side of ELN. In 39 families informative for
etion causes ì re-cal data, collected in a standardized quantifiable format d  fo|. ocher gentvs ¡„ the del................. .... . .
revealed s,gn«hcantly more severe growth retardation and ,m inh WS features. The deletion was found to be
microcephaly in the maternal deletion group. An imprinted 
locus, silent on the paternal chromosome and contributing 
to statural growth, may be affected by the deletion.
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“submicroscopie" (Ewart et: al. 1993; Nickerson et al. 
1995) and had not been characterized at the molecular 
level with respect* to heterogeneity of size and location 
of the deletion breakpoints until the recent report of 
Robinson et al, (1996)
Despite the consistency of the overall clinical pattern, 
the spectrum of anomalies in WS patients is very wide, 
and there is significant phenotypic variability among pa­
tients (Lopez-Rangei et* al. 1992). Even the cardiovascu­
lar features are present only in a subset of patients with 
ELN hemizygosity (Kotzot et aL 1995*7; Lowery et al. 
1995; Mari et al. 1995; Nickerson et ah 1995). The
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variability in the phenotype could be due to differences 
in the size of the deletions, but as yet there is no evidence 
that different genomic regions or genes are associated 
with particular phenotypic features. The phenotype 
could also be modified by variation in gene content or 
gene activity of the hemizygous alleles on the nondeleted 
chromosome. Gametic imprinting, defined as the total 
or partial inactivation of an allele as a consequence of 
having passed through gametogenesis in one parent, 
does not appear to play a major role in the causation 
of WS, because there are established cases of maternal 
and paternal transmission of WS and deletions in de 
novo WS cases have been reported to occur on either 
parent’s chromosome 7 (Ewart et al. 1993; Gilbert-Dus- 
sardier et al. 1995; Kotzot et al. 1995a; Nickerson et 
al. 1995). The clinical phenotypes, however, have not 
been analyzed in detail with respect to the parental ori­
gin of the deletion.
In this study, we investigated the frequency of 
7qll.23 deletions in 65 WS patients. By genotyping 13 
polymorphic loci from the 7qll-q21 region, we deter­
mined the approximate size of the deletions and the 
parental origin of the deleted chromosomes. We then 
attempted to correlate the molecular findings with the 
clinical phenotype of the patients in order to determine 
whether there is a molecular basis for the phenotypic 
heterogeneity in the disease.
Patients and Methods
Patients and Phenotypic Evaluation
Sixty-five patients with a clinical diagnosis of WS were 
ascertained through clinical geneticists at the Lucile 
Salter Packard Children’s Hospital, Stanford (n = 10), 
the Children’s Hospital of Philadelphia (n = 32), the 
University Hospital Nijmegen (n = 9), the Children’s 
Hospital at Denver (n = 2), and the Williams Syndrome 
Association (n = 12). All patients were nonfamilial ex­
cept for two sets of second cousins, both reported else­
where (White et al. 1977; Sujansky et al. 1995), and a 
set of monozygotic twins. None of the parents had fea­
tures of the WS, indicating that all cases were de novo 
presentations. The patients represented various ethnic 
groups (e.g., Caucasians, Hispanics, Asians, and Afri­
can-Americans). To collect uniform clinical data, a score 
sheet/questionnaire containing historical, clinical, and 
anthropometric parameters was prepared on the basis 
of the description of the phenotype in the literature. 
Fifty-three patients were clinically examined, and/or 
their medical records were reviewed by several of the 
authors. Each patient underwent a full generic and 
dysmorphology evaluation with careful attention to doc­
umenting critical features of WS, as well as complete 
cardiac and ophthalmologic examinations. Echocardio­
grams were performed when warranted by physical 
findings.
The frequencies of the clinical features in our WS 
population are summarized in table 1. Anthropometric 
measurements were expressed as standard deviation 
scores (SDS) for age and sex, according to the U.S. stan­
dards of Tanner and Davies (1985). Correction for pa­
rental heights was performed when available (Tanner 
et al. 1970). Statural data were also compared to the 
standards of the WS population established by Pankau 
et aL (1992). Twelve additional patients who had carried 
a possible diagnosis of WS were considered not to meet 
clinical criteria and were excluded from the study. Most 
patients had received routine cytogenetic analyses prior 
to entering the study. High-resolution prometapha- 
PHAse chromosome analysis (~850 bands) was per­
formed on five patients in the Clinical Cytogenetics Lab­
oratory at Stanford.
In order to determine whether a difference was detect­
able between groups of patients with different molecular 
results, the following clinical features were analyzed: 
parental age at conception; duration of gestation; birth 
weight and length; history of irritability or feeding prob­
lems in infancy; hypercalcemia before and after 2 years 
of age; height, weight, and head circumference at the 
time of last evaluation; degree of cardiovascular involve­
ment; degree of mental retardation; behavior; skeletal 
and connective tissue anomalies (joint elasticity, joint 
contractures, vertebral deformities, and inguinal/umbili­
cal hernias); esotropia-strabismus; hoarse voice; and 
hyperacusis. Cardiovascular disease was classified into 
severe (requiring therapeutic intervention such as sur­
gery or continued medication), moderate (significant 
cardiovascular anomaly), mild (borderline vascular ste­
noses by echocardiogram without hemodynamic sig­
nificance or borderline high blood pressure or mitral 
valve prolapse), and absent. Mental retardation was 
classified into severe (IQ < 40), borderline (IQ >  75), 
and mild/moderate (IQ between 40 and 75). Patients in 
whom no IQ testing was performed were considered 
mild/moderately retarded on the basis of clinical impres­
sion.
i
FiSH
Blood samples were obtained with informed consent 
from all the WS patients and from parents of 39 pro­
bands on the basis of protocols approved by the Human 
Investigation Committees of each participating institu­
tion. Chromosome spreads were prepared from short­
term phytohemagglutinin-stimulated lymphocyte cul­
tures. Two-color FISH was performed on 12 patients. 
A PI phage clone containing the 5' of the elastin gene 
and a P'l clone containing the calcitonin-receptor gene, 
mapped to band 7q21.3 outside the WS deletion, were
Table 1
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Frequencies of Clinical Features in our WS Patients
Feature Frequency (%)
Time of delivery (at term) 37/43 (86.0)
Time of delivery (preterm) 2/43 (4.6)
Time of delivery (postterm) 4/43 (9.3)
Birth weight <3% 8/44 (18.2)
Birth length <3% 4/28 (14.3)
Irritability/FTT in infancy 33/41 (80.5)
Hypercalcemia before 2 years 5/13 (38.5)
Hypercalcemia after 2 years 3/33 (9.1)
Height at examination <3% 13/42 (30.9)
Weight at examination <3% 19/42 (45.2)
OFC at examination <3% 11/34 (32.3)
Craniofacial:
Dolichocephaly 16/28 (57.1)
Bitemporal narrowing 26/32 (81.2)
Medial eyebrow flare 22/33 (66.7)
Periorbital fullness 42/44 (95.5)
Epicanthal folds 27/38 (71.0)
Stellate irides 30/45 (66.7)
Flat nasal bridge 37/41 (90.2)
Short, upturned nose 37/41 (90.2)
Flat malar region, full cheeks 43/43 (100.0)
Long smooth philtrum 35/42 (83.3)
Full lips 42/43 (97.7)
Dental abn/malocclusion 25/31 (80.6)
Cardiovascular disease:
SVAS 24/48 (50.0)
Peripheral pulmonary stenosis 13/48 (27.0)
Mitral valve prolapse 5/48 (11.4)
High blood pressure 5/25 (20.0)
Other (atrial or ventral septum defect) 2/48 (4.5)
Mental retardation:
Severe (IQ <49) 6/46 (13.0)
Mild/moderate 36/46 (78.3)
Borderline (IQ >75) 4/46 (8.7)
Behavior/Personality traits:
O utgoing/gregarious 38/42 (90.5)
Relative language strength 28/37 (75.6)
Hyperactivity-—’ADDa 18/42 (42.3)
Skeletal and connective tissue:
Joint hyperelasticity 21/43 (48.8)
Joint contractures 13/45 (28.9)
Kyphosis 3/45 (6.7)
Lordosis 10/45 (22.2)
Scoliosis 4/45 (8.9)
Radioulnar synostosis 3/45 (6.7)
Extra sacral crease 3/21 (14.3)
Inguinal/umbilical hernia 13/46 (28.3)
Genitourinary tract:
Congenital malformation 2/46 (4.3)
Enuresis/bladder dysfunction 17/25 (68.0)
Nephrocalcinosis 2/46 (4.3)
Esotropia 15/45 (33.3)
Hoarse voice 31/41 (75.6)
Hyperacusis 28/33 (84.8)
a Attention deficit disorder.
labeled with digoxigenin-ll-dUTP and biotin-16-dUTP, 
respectively, by nick-translation, and hybridized simul­
taneously to denatured metaphase spreads as reported 
by Pérez Jurado et al. (1995).
ELN Gene Dosage Analysis
For gene dosage analysis by Southern blotting, geno­
mic DNA from 59 patient samples was digested with 
EcoRl (New England Biolabs), fractionated by electro­
phoresis through 0.8% agarose gels, and transferred to 
Hybond N membranes (Amersham). Blots were hybrid­
ized simultaneously with a 660-bp PCR-amplified probe 
containing exons 20 and 21 of the ELN gene (Tromp 
et al. 1991) and with a 550-bp PCR-amplified product 
containing exons 2 and 3 of the growth hormone-re- 
leasing hormone gene (GHRH) on chromosome 20q as 
reference probe (Pérez Jurado et al. 1994). Hybridiza­
tion signals were compared by densitometric analysis 
using the ImageQuant software (Molecular Dynamics). 
Hemizygosity was defined as a mean signal strength ra­
tio <0.6 after two evaluations.
Polymorphic Marker Typing
For geno typing, 13 polymorphisms from the region 
were analyzed by PCR. The exon 20-intron 20 region 
of the ELN gene containing two RFLPs were PCR ampli­
fied as described by Tromp et al. (1991), and the prod­
ucts were digested with B s iN l (New England Biolabs), 
separated on a 5 % agarose gel, and detected by ethidium 
bromide staining. A tandem repeat sequence within an 
intron of the ELN locus (originally published as intron 
17 and renumbered intron 18 by Bashir et al. [1989]) 
was also utilized for genotype analysis (Foster et al. 
1993), as well as marker AFMa060xc9 (locus 
D7S1870), which was reported to be deleted in some 
WS patients (Gilbert-Dussardier et al. 1995). Other 
polymorphic microsatellite loci mapping near the critical 
region were identified through the Genome Data Base 
(GDB) and/or the public data releases from the CEPH 
and the Whitehead Institute Center for Genome Re­
search (Dib et al. 1996; Hudson et al. 1995). PCR reac­
tions were carried out in mixtures containing 40 ng of 
genomic DNA, 150 ]iM of each dNTP, 10 mM Tris- 
HC1 pH 8.9, 50 mM KC1, 1.5 mM MgC12, 1 jllCí 32P 
dCTP or 1.5 jnCi 35S dATP, and 0.5 units of Taq poly­
merase in a total volume of 12.5 (il. Samples were pro­
cessed through 32 cycles (1 min at 94°C, 1 min at 55°C, 
and 1 min at 72°C) and a final extension step of 7 min 
at 72°C. The PCR products were visualized by autoradi­
ography following electrophoresis in 6% denaturing 
polyacrylamide gels.
Genetic and Physical Mapping o f 7q1 Uq21 
Polymorphic Markers
Eight reference families of the CEPH panel (Gyapay 
et al. 1994) were genotyped for the polymorphic loci
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D7S489 (AFM136xe3), ELN BstNl RFLP, and 
D7S1870 (AFMa060xc9). The results were compared 
with those of other markers previously assigned to 7q 
by using version 5.1 of the LINKAGE software package 
(Lathrop et al. 1984). Recombination frequencies were 
assumed to be equal in males and females. YAC clones 
containing the loci D7S489 and D7S1870 were kindly 
provided by Stephen Scherer and Lap-Chee Tsui, Uni*' 
versity of Toronto, from a chromosome 7-specific YAC 
library (Kunz et al 1994). Other YACs containing 
D7S489 loci, as well as the overlapping YACs, were 
identified on the basis of sequence-tagged-site (STS) con­
tent information available through data releases of the 
Whitehead Institute—M i.T  Human Genome Mapping 
Project (Hudson et al. 1995) and were obtained from the 
German Genome Project Resource Center at the Max 
Planck Institut Berlin-Dahlem. PCR-ampIified products 
with primers specific for AFM136xe3 were cloned into 
the TA cloning vector PCRTMII (Invitrogen) and se­
quenced using the Sequenase 2.0 reagents (Stratagene).
Statistical Analysis
For statistical analysis, Student’s i-test or Kruskal- 
Wallis test and the %2 test were applied as appropriate. 
A level of confidence of P = .05 was used to assume a 
statistically significant difference.
Results *
Detection of ELN Deletions in WS Patients by Dosage 
Analysis and FISH
Quantitation of Southern blot hybridization signals 
revealed an ELN dosage reduced by ~50%, consistent 
with hemizygosity at the ELN locus, in 56 (94%) of the 
59 patients analyzed. Figure 1 includes two patients’ 
samples (1244 and 1260) with apparently normal ELN 
gene copy numbers (intensity values > 0.9), who were 
later determined not to have WS. FISH generated an 
ELN-specific signal on only one chromosome 7 in 10 
of 12 WS patients studied. In contrast, the calcitonin- 
receptor gene-containing PI clone consistently hybrid­
ized to both chromosomes 7 in all patients tested (not 
shown). Cells from two WS patients who had normal 
ELN gene dosage revealed ELN-specific FISH signals on 
both copies of chromosome 7, as did controls. Alto­
gether, hemizygosity at the ELN locus was found in 61 
(94%) of the 65 patients analyzed by either one or both 
of the methods described above, while 4 (6%) WS pa­
tients were not deleted at ELN.
Physical and Genetic Mapping of Markers Flanking the 
ELN Gene
PCR amplification with primers for the microsatellite 
marker AFM136xe3 detected two major polymorphic
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•sf ID
in
<\J CM CM
9.4 kb
ELN/GHRH .54 .59 .51 .36 .51 .55 .44 1.0 .66 .48 .45 1.0 .98 1.0
Figure 1 Elastin gene dosage analysis by Southern blotting. A 
membrane with jBcoRI-digested DNAs from several WS patients and 
controls (NC) was simultaneously hybridized with two probes, one 
specific for elastin ELN and the other for growth hormone-releasing 
hormone (GHRH). ELN/GHRH signal intensity ratios derived from 
densitometric analysis are given below each lane. NCI was taken as 
the standard by assigning it a ratio value of 1.0.
loci in normal individuals, named “D7S489A” and 
“-B,” that are distinguished on the basis of size differ­
ences. Alleles at D7S489A range between 138 and 146 
bp and at D7S489B between 168 and 180 bp. Cloning 
and sequencing of PCR products in the respective size 
ranges revealed very high sequence identity (97%) with 
the expected changes in the length of the (CA)n repeat 
and minor differences in the flanking regions (not 
shown). The observed heterozygosity in 80 unrelated 
normal individuals was 60% at D7S489B and 35% at 
D7S489A. PCR amplification of a panel of somatic cell 
hybrids (Francke et al. 1986) verified that both D7S489 
loci map to the long arm of chromosome 7. Linkage 
analysis using a partial CEPH panel revealed that 
D7S489A and -B, ELN, and D7S1870 belong to a link­
age group on chromosome 7 with the most likely order 
of loci determined by multipoint analysis as shown in 
figure 2. In family 1413, a crossover event between 
D7S2476 and ELN/D7S613 was found on the maternal 
chromosome of individual 1413-04. In family 1362, a 
crossover was observed between ELN and D7S1870 on 
the paternal chromosome (fig. 2). D7S489A was not 
informative in these families.
Therefore, two YAC clones containing D7S489A were 
identified, both of which were also positive for D7S1870, 
indicating that D7S489A is telomeric to ELN. One of 
these YACs also contained the locus D7S2472. One inde­
pendent YAC was found to contain D7S489B, as well as 
the low heterozygosity marker AFM116yg5 (locus 
D7S1778). D7S1778 allowed us to physically link this 
clone with other YAC clones containing the highly poly­
morphic STS loci D7S1816, D7S1483, and D7S653 (fig. 
2). All the YACs from this region are highly unstable, and 
different insert sizes were obtained in different isolations. 
Thus, no precise estimate of the physical distance between 
markers can be obtained from this YAC contig.
Molecular Definition of the Deleted Region
The results of genotyping multiple polymorphic mark­
ers in WS patients are summarized in figure 3. A failure
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Figure 2 Genetic and physical mapping of the deletion region, Top, Haplotypes of five representative members each of CM PH families 
1413 and 1362 typed for multiple polymorphic markers from 7ql 1,23* Haplotypes from the nonreeombiuing parent'are in Roman font, while 
from the recombining parent' one haplotype is shown in bold, ami the other in italics, A crossover event between D7S2476 and D7S613/ELN 
on the maternal chromosome of individual 1413-04 that positioned D7S4H9B/D7SIK16 and D7S2472 to either side of the crossover. In family 
1362, recombination between KLN and D7S1870 is evident on the paternal chromosome ot 1362-09, Data on nonrecombinant siblings with 
the parental haplotypes are shown as reference. Middle* Most-likely order of loci, as determined by multipoint linkage analysis. Genetic distance 
between the markers is in eentimorgans. liattom, Partial physical map with contigs of YAC clones, aligned on the basis of STS content, that 
encompass the deletion breakpoints, The deleted interval with the location of the common breakpoints is shown below. Single asterisks (*) 
represent YAC.' clones from the chromosome 7-speciiic YAC library (Kunz et a I. 1994). Double asterisks (**) represent YAC clones from the 
OKPI I MegaYAC library (Hudson et al. 1995),
of parental inheritance could be detected at locus
D7S489B in 15 (38.5%) of 39 patients, ELN(CA)n18 in 
11 (29.7%) of 37, ELNBstNl RFLP in 13 (33,3%) of 
39, D7S613 in 9 (47.4%) of 19, D7S2472 in 23 (59%) 
39, D7S2476 in 9 (33,3%) of 27, and D7S1870 in 24
(63.1%) of 38. Examples of genotyping results at the 
seven intradeletion markers are shown in figure 4. Lack
(AF~M289ve9), D7S653 (AFM259zct), D7S1483 
(IJT5719), D7S1816 (CiATA2ID 12), D7S675 (Al- 
M295yg9), and D7S669 (AFM286xf9)1 which are, 
therefore, outside of the critical deleted region.
It is interesting that, while one of the loci detected 
with the AFMI36xe3 primers (D7S489B) revealed 
hemizygosity in all informative patients, the related lo­
ot inheritance of a parental allele involved the maternal cus D7S489A did not. Heterozygosity at D7S489A was
(21 cases) or the paternal (18 cases) allele and was con- 35% in patients, similar to that reported for control
sistent at all informative loci. No patient hemizygous at individuals (GLIB), indicating that this locus is outside
ELN was heterozygous at any of these loci, suggesting the deletion in most WS patients, The common telomeric
that there is a commonly deleted interval from D7S489B 
through D7S1870. Normal codominant inheritance 
was found for the following polymorphic loci (marker HSC7E640 and HSC7S902 (see fig. 2), In light of the 
names in parentheses): D7S645 (AFM238zc9), D7S672 low informativity of locus D7S1778, we used other
breakpoint, therefore, is located between D7S1870 and 
D7S489A, a region covered by the
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Figure 3 Composite results of genotyping multiple polymorphic loci in WS patients. In the top row are patients for whom parental 
samples were available, and the maternal (M) or paternal (P) origins of the deletions are indicated. To the right are the four patients in whom 
no deletion was detected. The bottom row contains results on patients with no parental samples available. Markers are ordered centromere to 
telomere. The loci from D7S489B through D7S1870 are deleted in all informative patients and, therefore, define the common WS deletion 
interval.
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Figure 4 Genotyping of the seven intradeletion markers in WS families. Failure of parental inheritance of one allele, represented by a 
minus sign (-), due to de novo deletions, is observed in all cases.
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markers contained in overlapping YACs to define the 
centromeric extension of the deletion. High levels of 
heterozygosity at the centromeric flanking loci D7S1816
(40 (66%) of 61), D7S1483 (12 (75%) of 16), and
D7S653 (11 (92%) of 12) indicate that these loci are 
consistently outside the deletion and that the common
centromeric breakpoint lies between D7S1816/D7S1483 
and D7S489B, within the partial YAC contig.
As loci flanking ELN at a distance of 1 cM to either 
side are within the deletion, a deletion size approaching 
2 mbp is suggested. Thus, we hypothesized that the dele­
tion may be detectable microscopically. We retrospec­
tively examined high-resolution (~650-750 bands) 
karyotypes from five WS patients and found subtle dele­
tions of one chromosome 7 at band q l 1.23 in the major­
ity of cells. No band is missing, but a reduction in the 
size of band q 1 '1.23 causes the grey band q ll.22  to be 
located in the middle of q'11.2 instead of its normal 
position closer to q l l . l  as indicated on the ideogram 
of the high-resolution banding pattern of normal chro­
mosome 7 (Francke 1994). While this deletion is clearly 
at the limit of detection by light microscopy, our findings
Family 1 Family 2
D O a
D7SÓ53 1 3 1 2 2 10 1 1 1 1 1 1 1 2 2
D7S1816 2 3 7 2 2 2 1 3 1 3 3 1 1 3 2 3 3 5 3 ? 3
D7S489B 2 2 w I 1 2 2 1 2 - 1 1 7 4 2 4 A 2 4 7 4 y
D7S2476 1 1 7 1 1 4 1 2 1 7 1 3 7 2 1 2 2 I 2 7 T*
D7S613 2 2 ? 2 2 3 2 2 2 7 2 3 7 1 2 1 1 1 1 7 1
ELN-I18 1 3 ? 1 1 1 1 3 1 7 1 4 1 1 1 1 1 3 I 7 1 4
ELN-E20 2 3 d 2 2 3 2 3 2 (1 1 2 7 2 2 2 2 1 2 «V 1 1
D7S2472 6 f i « 2 2 8 3 8 3 ? 3 7 7 7 3 7 7 7 7 - 1 5
D7S187Ü <1 fl 7 4 4 4 4 .*) 4 ? 4 5 ? 3 1 3 3 4 3 « 2 «'I
D7S489A 2 2 2 1 1 2 2 1 2 1 1 1 ? 2 2 2 2 1 2 7 2 t
D7S669 9 5 9 4 4 5 4 5 4 1 I 5 ? 1 3 I 1 2 1 2 2 4
Figure 5 Haplotypes of 7ql 1.23 loci in two kindreds with famil­
ial Williams syndrome. The letter d indicates deletion by dosage stud­
ies, a minus sign ( —) indicates deletion of a parental allele, and a 
question mark (?) indicates hemi- or homozygozity. The deleted cliro* 
mosome is paternally derived in the three fully informative cases, lit 
the one case with paternal sample not available (NA), the data are 
consistent with paternal origin of the deletion. These results rule out 
a maternally inherited, identical-by-descent 7q region that is uniquely 
predisposed to de novo deletion formation.
could be detected. Clinical réévaluation of these four 
patients was consistent with a diagnosis of WS based 
on the presence, during some period of development, 
of characteristic facial features, mental retardation ,and 
strongly suggestive cognitive and personality profiles. 
Three of them were at or above the 50th percentile for 
height and head circumference (on normal growth
M*
support the notion of a ~2-mbp deletion size, as deter­
mined by the genetic and physical mapping studies and 
the genotyping results in WS patients.
Familial WS Due to Independent Mutational Events
We have studied two sets of second cousins with a charts). None of them had hypercalcemia or any vascu
clinical diagnosis of WS. In both families, no other mem- lar stenoses; the only cardiac anomaly was a defect in
her had signs of WS, and the mothers were related as the atrial septum secundum in one of them. Their fea-
first cousins. Deletion studies by dosage determination tures are included in table '1. 
and/or KISH analysis demonstrated hemizygosity at the
ELN locus in each of the four probands. Normal results Genotype/Phenotype Correlations in WS Patients with
on all of the seven available parents confirmed the de  ^ 7q11.23 Deletion
novo deletions in the probands. Pedigree analysis sug- No variability in the size of the deletion could be
gested the possibility of a chromosome 7 region, identi- detected between WS patients by genotyping of poly-
cal by descent, that might* predispose to the 7qll.23 morphic markers, suggesting that the chromosomal
deletions. Genotyping of multiple intradeletion poly- breakpoints may consistently fall into narrowly defined
morphisms revealed, however, that the deletions had physical regions. To search for other parameters that
occurred on the paternally inherited chromosome 7 in could provide possible correlations with clinical fea-
three of the four patients (fig, 5). Although the father in tures, we tested for an amino acid polymorphism in
family 2 was deceased, the available data are consistent the single remaining ELN gene and also determined the
with a paternal origin of this deletion, as well. Since the parental origin of the deletions.
deletions affected the chromosome 7 contributed by the The ELN BstNi polymorphism represents a protein
noncoiisanguineous parents, each of the four deletions variant with either serine or glycine at amino acid posi
must represent an independent mutational event, and 
the occurrence of two cases within the same families is 
likely due to chance.
tion 422, with allele frequencies of 42% and 58%, re-* 
spectively, in the general population (Tromp et al. 
1991). This amino acid variant could convey a subtle 
difference in function of the protein or could be in dis-
CHnical and Molecular Evaluation of Patients with No equilibrium with another allelic variant with functional
Demonstrable ELN Deletions significance. Thirty-three patients (56%) had a Sei.422
All four patients with normal dosage at the ELN locus in the nondeleted allele, while 26 (44%) retained an
had biparental inheritance at all informative loci tested. ELN allele with Gly422. No significant difference was
Thus, no molecular defect, such as a smaller deletion, observed between the two groups with respect to their
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physical, cognitive, connective tissue, or cardiovascular ated. More complex rearrangements, such as noncontig-
manifestations (P > .2, in all cases).
Search for Parent-of-Origin Effects on the Phenotype in 
WS Patients with Deletions
uous deletions, were not defected. In a report that ap­
peared after our paper was submitted, Robinson et al.
(1996) identified two cases with hemizygosity at 
D7S489A (called ctD7S489L” in their paper) and seven
The parental origin of the deleted allele could be un- who were heterozygous at this marker. In our series, 21 
equivocally determined in 39 cases. Statistical analysis of 61 cases were heterozygous and the rest were either 
of the clinical variables (table 2) revealed a significant hemi- or homozygous. Thus, it is possible that some 
correlation between the degree of growth retardation heterogeneity exists with respect to the location of the 
and parental origin. In patients with a maternally de- distal breakpoint (although Robinson et al. placed
D7S489L proximal to ELN, we have convincing evi- 
dence from our physical mapping studies that it is in the 
distal flanking region).
The size of this common deletion can be estimated by
rived deletion, the mean height was -1.5 SDS (± 0.94), 
and in paternal deletion patients it was —0,5 SDS 
(± 1,06) (P = .015). Because WS girls are slightly more 
growth retarded than boys and have earlier pubertal
development, the observed statural differences could be the fact that we were able to detect it on high-resolution 
biased because of sex and/or age differences between the banded chromosomes. The reason why cytogenetic dele- 
two groups. To correct for such a bias, we also com- tions at 7qll.23 have not generally been reported in 
pared the height of each patient with the standards for WS patients may be due to their location within a single 
age and sex of the WS population (Panlcau et aL 1992). large R-band (7ql 1.23) that could contain mbp of 
The correlation was still evident, with maternal deletion DNA. Only with careful attention to the relative posi­
tion of band 7qll.22 within the entire 7ql'1.2 region 
on elongated chromosomes can a reduction in the size 
of band 7qll.23 be appreciated in the majority of cells. 
The deletion size estimate of '1.5-2.5 mbp is consistent 
with the 2% recombination between intradeletion ge­
netic markers.
The Deletion Breakpoints Occur at Duplicated
patients having a mean height of —0.58 SDS (± 0.67) 
and paternal deletion patients having a height of 0.28 
SDS (± 0,86) (P = .007). Similar correlations were ob­
served for weight (maternal deletion: mean weight 
— 1.48 SDS± 1.80; paternal deletion: mean weight 
—0.65 ± 0.96) (P = ,017) and head circumference
(OFC) (maternal deletion: mean OFC -1.71 ± 0.52; 
paternal deletion: mean OFC —0.71 ± 1.02) (P
.0007), Birth parameters did not show a significant Regions of Sequence Homology
variation between the two groups of patients, suggesting 
a more severe growth retardation of postnatal onset in 
the group of WS patients with a maternal deletion. No 
significant difference was observed between the two 
groups with regard to the presence and/or severity of
WS occurs sporadically in >99% of cases with a mu­
tation rate close to 5 X 10 5. The frequency of WS 
deletions is the same in maternally and paternally inher­
ited chromosomes, and no parental age difference is ap­
parent between the two groups. Primers for AF-
other phenotypic features (table 2). No parental age ef- M136xe3 amplify two or more products that are
feet was apparent in either group.
Discussion
The 7ql 1.23 Deletion Is Common and Consistent 
in Size
Most patients with a clinical diagnosis of WS (61 
(94%) of 65) were found to have a heterozygous dele­
tion at chromosomal band 7ql 1.23 as detected by quan- (Perez Jura do et al. 1996). The repetitive nature of these
chromosome 7-specific and highly polymorphic be 
tween individuals. At least two of these D7S489 loci, 
with >97% sequence identity, are located close to the 
common deletion breakpoints: D7S489B is near the cen- 
tromeric breakpoint and is included in the deletion, 
while D7S489A is outside the deletion but close to the 
telomeric breakpoint, Other sequences within this re­
gion in the vicinity of the breakpoints are also duplicated
titative Southern blotting or FISH studies with ELN gene 
probes. This fraction is similar to that reported by others 
(Kotzot et al. 1995#; Lowery et al. 1995; Mari et al. 
1995; Nickerson et al. 1995). To determine whether the
sequences and their clustering within a relatively small 
chromosomal interval provides a hypothetical mecha­
nism for aberrant recombination or r° ation events,
either by unequal crossover or intrachromosomal rear-
deletions are heterogeneous in size, we first established rangement, that may lead to the high frequency of de
the locus order for multiple genetic markers in the novo deletions in these regions. Similarly, Iow-copy- 
7qll.23 region by using a combination of meiotic and number repeat sequences are present within other dele-
physical mapping strategies. When all 65 WS patients tion-prone chromosomal regions, such as the Kallmann
and available parents were typed for these polymorphic syndrome region at Xp22.3, the DiGeorge/velo-cardio-
markers, a commonly deleted interval could be deline- facial syndrome region at 22ql I, the Prader-Willi/
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Table 2
Comparison of Clinical Findings between Williams Syndrome Patients with a Deletion on the Maternally and the Paternally Inherited 
Chromosome 7
Featuiu-
Male/Female
Age at clinical evaluation 
Paternal age (years)
Maternal age (years)
Time of delivery (at term: 37-42 wk) 
Time of delivery (preterm/postterm) 
Birth weight (SDS)
Birth length (»SDS)
Irritability/Failure to thrive in infancy 
Hypercalcemia before 2 years 
Hypercalcemia after 2 years 
Anthropometric data (SDS):
Height (vs, WS population)
Height (vs. general population) 
Weight (vs, general population) 
OFC (vs. general population) 
Cardiovascular disense/stenoses:
Moderate 
Mild
No
Mental retardation:
Severe (IQ <40) 
Mild/moderate 
Borderline (IQ >75) 
Behavior (>3 years of age):
i^/gregarious 
Hyperactivity—
Skeletal and connective tissue: 
Joint hyperelasticity 
Joint contractures 
Vertebral deformities 
I ng 11 i u a 1/u m b i 1 i ea 1 h or n i a 
Rsotropia 
Hoarse voice 
Hyperacusis
M a t e r n a i .
Mean or %
35/65 
6.95 
30.0 
28.06 
75 
12.5/12.5 
" " " ■  1.45 
■1.12
75
50
15.3
-.58
1.50
1.48
1.7!
22.2
5.6
44.4
27.8
12.5 
75
12.5
93.3 
4 6.6
56.2
31.2
37.5
37.5
31.2 
80
100
SD
*  ♦ *  
6.93 
7.35 
6.06 
« f  I 
•  4 4
0,95
1.24
1 4 #
4 4 4 
+ 4 4
,67
.94
1.80
.52
I « •
V * »
I  I  «
1 « »
1 1 1
4 * «
4 4 ¥
4 * 4
* * *
I I •
I  « I
n
20 
16 
16 
.6 
6 
16 
16 
9 
16 
4 
13
16
16
16
12
18
18
18
18
16
16
16
15
15
16
16
16
18
16
15
12
Pa t e r n a l
Mean or %
50/50
10.16
30.43
28,73
86.7
0/13.3 
■*•*"1,01 
-.74 
78.6 
50 
7.7
.28
™,50
-.65
-.71
20
13.3
53.3
13.4
6.7
80
13.3
92.8
42.8
53.3
23
46.2 
20
33.3 
66.7 
88.9
SD
4 4 4
6.60 
4,60 
4.22 
4 I 4 
4 4 t
,97 
.82 
4 4 4 
I » * 
1 1 4
,86
1.06
.96
1.02
♦ 4 4
I  » I
I I é
I  I  I
4 4 4
• 4 4
I  « »
4 I I
♦ ♦ i
I  I  «
I  I  4
•  I
4 * 4
4 4 4
4 4 4
n
18
15
14
16 
151 
15.
15
9
14
4
13
13
13
13
10
151 
15 
15
14
14
15
13
13
15
15
12
9
P
(a =  .05)
• ft
P( 1) =  .198 
P(l) =  .850 
P(l) =  .723
P(3) =  .187
P(l)
P(l) 
P( 3) 
P(3) 
P(3)
Pd )
P(l) 
P( 2) 
P( 2)
.216
.456
*893
1.0
.587
.007
.015
.017
.0007
P(3) = .682
P(3) = .860
P(3)
P(3)
P(3)
P(3)
P(3)
P(3)
P(3)
P(3)
P(3)
.936
.887
,913
.624
.638
.283
.901
.432
.308
NoTK,**~*In forma lion on each trait was not available for all patients; SDS ^  standard deviation score, OFC •-= occipital-frontal circumference, 
ADD - (attention deficit disorder); /’ (I) - Student's /-test; P(2) - ; Kruskal-Wallis test; P(3) - %l test. P-values in hold are statistically 
significant,
Angelman syndrome region I5ql l-ql3, the spinal mus­
cular atrophy region at 5q'13, and the 21-hydroxylase 
genes on 6p (Sinnott et* al. 1990; Yen et al. 1990; Bui tin g 
et al. 1992; Halford et al. 1993; Theodosiou et al. 1994).
To explore the possibility of an inherited predisposi­
tion to deletion formation, we studied two kindreds in 
which a set of second cousins had been diagnosed with 
WS. All four pr
clustering is likely due to chance, in light of the high 
mutation rate of WS, These observations are relevant 
for studies of other diseases in which distantly affected 
relatives are often assumed to harbor abnormal alleles 
that are identical by descent.
Phenotype/Genotype Correlations
The overall clinical spectrum of anomalies and the 
chromosomes inherited from the nonconsanguineous phenotypic variability among individuals in our WS 
parents. Kach of the prohands, therefore, has WvS caused population are similar to previous reports (Kotzot et al. 
by an independent mutational event, and the familial 1995^ /; Lowery et al. 1995). Cardiovascular manifesta-
: novo iions on
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tions are present in ~75%, with SVAS the most com­
mon (in 50%), followed by peripheral pulmonic stenosis 
(in 27%). Since disruption of the ELN locus by translo­
cation or deletion causes cardiovascular manifestations
identical to those of WS patients (Curran et al. '1993; 
Ewart et al. 1994; Olson et al. 1995), haploinsufficiency 
for ELN must be responsible for the cardiovascular man­
ifestations of the syndrome. Whether the ELN gene dele­
tion alone accounts for other connective tissue manifes­
tations—the periorbital fullness and thick lips, inguinal 
hernias, skin and joint changes, diverticula of bladder 
and intestine—remains to be investigated.
The four patients with clinically defined WS without 
detectable deletion had some of the characteristic facial 
features and cognitive defects, but three of them were 
within the normal range for growth, and none had car­
diovascular stenoses. Neither did the three nondeleted 
patients reported by Nickerson et al. (1995) and the two 
by Borg et al. (1995). No other cytogenetic abnormali­
ties were present. These patients may have more subtle 
7qll.23 deletions or point mutations in genes that map 
within the deletion or elsewhere, because there are sev­
eral reports of WS cases with abnormalities involving 
chromosomes 4, 6, 13, and 18 (Jefferson et al. 1986; 
Bzduch and Lukacova 1989; Colley et al. 1992).
The cardiovascular abnormalities are not fully pene­
trant in the presence of a deletion, and the clinical sever­
ity is quite variable among patients. This nonconcor­
dance between ELN deletions and cardiovascular 
phenotype may be due to allelic variation associated 
with differential ELN expression or function, modifier 
genes at other loci, or stochastic processes. We excluded 
a possible correlation between a protein polymorphism, 
either serine or glycine at amino acid position 422 of 
tropoelastia present on the retained ELN allele, and car­
diovascular abnormalities.
Parent-of-Origin Effects
Although it is well established that ELN deletions in 
WS patients are present on the paternal or the maternal 
chromosome at about equal frequency (Ewart et al.
1993; Gilbert-Dussardier et al. 1995; Kotzot et al 
1995b; Nickerson et al. 1995), possible parent-of-origin 
effects on individual phenotypic traits have not been 
examined. When we searched systematically for pheno­
typic differences between the groups of patients with 
paternally [n = 18) and maternally derived (n = 21) 
deletions, we found a significant correlation between 
more severe growth retardation and maternal deletion. 
To correct for differences in sex-ratio and/or mean age 
differences between the two groups, statural data were 
compared with the standards for the age- and sex- 
matched WS population (Pankau et al. 1992). That the 
significant difference in height measurements is not just
a statistical artifact is supported by significant differ­
ences in weight and head circumference, as well. Since 
weight and length at birth were not different, the more 
severe growth deficiency associated with maternal dele­
tions must be of postnatal onset. Two possible reasons 
for this clinical-molecular correlation have to be consid­
ered: (1) maternal deletions might be slightly larger in 
size than paternal deletions affecting additional gene(s) 
involved in growth control, or (2) one or several genes 
altered by the deletion might be imprinted with dimin­
ished or abolished expression of the paternal allele; dele­
tion of the maternal homologue(s) would lead to com­
plete or almost-complete gene silencing causing growth 
retardation. Although the first possibility cannot be 
completely ruled out, since the size estimate of the dele­
tion is still rough, we favor the second hypothesis, the 
existence of paternal gametic imprinting in the WS re­
gion. This tentative conclusion needs to be evaluated 
by studies of a larger sample. No differences in other 
phenotypic features dependent on the parental origin of 
the deletion were found, indicating that gametic im­
printing does not play a role in the variability of those 
features.
There is evidence for at least one maternally imprinted 
gene on chromosome 7 that controls intrauterine and 
postnatal growth, but not for paternally imprinted 
genes. Maternal uniparental disomy (UPD) is associated 
with primordial growth retardation (Kotzot et al. 
1995&), beyond homozygosity for recessive mutations 
in some cases (Spence et al. 1988; Voss et al. 1989). A 
single patient with paternal UPD 7, detected on molecu­
lar investigation of congenital chloride diarrhea, did not 
reveal growth retardation (Hóglund et al. 1994). We 
have recently identified a gene that is hemizygous in WS 
patients, RFC2, encoding subunit 2 of the replication 
factor C (Peoples et al. 1996). The product of this gene
is an essential part of the enzyme complex responsible 
for DNA strand elongation during replication. Expres­
sion studies of RFC2 have not revealed any parent-of- 
origin effects. Mouse breeding experiments have not 
demonstrated any imprinting effects for chromosomes
5 where the murine elastin gene (Eln) is located (Beechey 
and Cattanach 1996).
Diagnostic Considerations
The diagnosis of WS based on clinical evaluation 
alone may be difficult because of the variability of the 
manifestations, but early diagnosis is desirable to assure 
parental counseling, adequate special education, and 
evaluation for, and treatment of, the associated medical 
problems. Molecular diagnosis can be accomplished by 
ELN dosage blotting or FISH. The availability of multi­
ple PCR-based polymorphic DNA markers that map 
consistently within the deleted interval allows for easy
Pérez Jurado et al.: Common Williams Syndrome Deletion 791
detection of hemizygosity and for identification of the 
parental origin of the deleted chromosome. Even in the 
absence of parental samples, in light of the high compos­
ite heterozygosity of these markers (99.97%), failure to 
detect heterozygosity is indicative of allelic loss and can 
be used as a diagnostic tool. The expected false positive 
rate is 0.3 per 1,000, in the absence of parental consan­
guinity.
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